Follow the stories of academics and their research expeditions
Abstract
Artificial
intelligence (AI) is increasingly embedded in health systems across Sub-Saharan
Africa (SSA), from tuberculosis (TB) screening with computer-aided detection to
large-scale digital triage. While the potential for impact is substantial,
scaling responsibly requires attention to governance, safety, equity, data
protection, capacity building, and sustainability. This secondary research
paper synthesizes recent guidance from the World Health Organization (WHO), the
African Union (AU), and national regulators, alongside case examples (e.g.,
AI-assisted TB radiography and digital triage in Rwanda) to derive pragmatic
lessons for implementers and policymakers. We find that (a) continental and
national governance frameworks are converging on rights-preserving, risk-based
regulation; (b) AI systems can achieve clinically meaningful performance in
priority areas such as TB screening, but require robust external validation and
post-market surveillance; (c) sustainability and vendor risk must be managed
proactively to avoid service shocks; (d) data protection regimes (e.g., Nigeria
NDPA 2023, Kenya ODPC health data guidance, South Africa POPIA) provide
enforceable obligations applicable to health AI; and (e) capacity networks
(e.g., DHIS2/HISP, Masakhane, Deep Learning Indaba, DS-I Africa) are critical
to localization and equity. We conclude with a practical checklist for
“responsible-by-design” scale-up in SSA health systems. ScienceDirect+4World Health Organization+4World Health
Organization+4
Keywords: Responsible AI, health informatics,
Sub-Saharan Africa, governance, data protection, TB screening, health equity
Introduction
The acceleration of
AI-enabled tools in global health has coincided with new policy guardrails.
WHO’s 2021 ethics report and 2023 regulatory considerations articulate
principles and pathways for safe, effective, and equitable AI in health,
emphasizing transparency, external validation, human oversight, and lifecycle
risk management. World Health Organization+1 In parallel, regional policy
has advanced: the African Union’s 2024 Continental AI Strategy endorses an
Africa-centric, rights-preserving approach to AI deployment, with clear
relevance for health programs. African Union
In SSA, AI deployments
are most visible where clinical gaps are largest and data are relatively
structured—e.g., TB screening with AI-assisted chest X-ray (CXR) and
algorithmic triage/chat-based navigation. Evidence and experience from these
frontlines offer concrete lessons for scaling responsibly.
Methods (Secondary
Research)
We conducted a
narrative synthesis of (a) multilateral guidance (WHO/AU), (b) peer-reviewed
studies on AI for TB screening, (c) national data-protection and sectoral
guidance (Nigeria, Kenya, South Africa, Ghana), and (d) ecosystem/capacity
sources (DHIS2/HISP, Masakhane, Deep Learning Indaba, DS-I Africa). Evidence
sources (2021–2025) were prioritized for recency and policy salience; where
appropriate, we include case-based reporting on digital triage deployments and
their failure modes. Government of South Africa+6World Health Organization+6World
Health Organization+6
Findings
1) Governance is
maturing: clear principles and risk-based regulation
WHO’s 2023 Regulatory
Considerations on AI for Health outlines expectations across the product
lifecycle—intended use definition, data governance, documentation, clinical
evaluation, post-market monitoring, and change management—while urging
context-appropriate regulatory capacity building. World Health Organization The AU’s 2024 Continental AI
Strategy complements these with continental priorities around ethics,
inclusion, capability building, and cooperation—relevant for cross-border
health data sharing and regional procurement. African Union
Implication: Ministries of Health (MoHs) and regulators can
adopt a risk-proportionate approach (e.g., higher scrutiny for
diagnostic/therapeutic AI; lighter touch for workflow optimization) and align
procurement with WHO’s documentation and evaluation expectations. World Health Organization
2) Clinical
performance can be strong—but depends on external validation and continuous
monitoring
CAD (computer-aided
detection) for TB on CXR has WHO endorsement as an alternative to human readers
for screening/triage in adults since 2021, with an implementation guide updated
in 2024–2025. Systematic reviews and recent external validations in South Africa
report CAD systems approaching radiologist-level performance for TB triage,
although thresholds require calibration to prevalence and program goals. ScienceDirect+3World Health Organization+3The Lancet+3
Implication: Programs should (a) perform local external
validation, (b) tune decision thresholds for their epidemiology and workflow,
and (c) establish post-market surveillance for dataset shift and version
changes—consistent with WHO guidance. World Health Organization
3) Sustainability
and vendor risk are central to “responsible scale”
Rwanda offers a
cautionary tale. Babyl (the local arm of Babylon Health) pioneered at-scale
AI-enabled digital triage and teleconsultation under a government partnership,
reportedly handling thousands of daily consultations. In 2023, following
parent-company bankruptcy, Babyl wound down Rwandan operations, creating a
service discontinuity and prompting sector reflection on contingency planning
and public digital infrastructure. DCCC+1
Implication: Health systems should require (a) escrow or
open interfaces for critical components, (b) data portability and exit plans,
(c) SLAs tied to continuity, and (d) preference for solutions that integrate
with national data backbones (e.g., DHIS2-based platforms; Rwanda’s new Health
Intelligence Center). DHIS2+1
4) Enforceable data
protection frameworks apply to health AI
SSA features a growing
patchwork of enforceable data-protection law with direct implications for
health AI:
Implication: AI implementers must conduct data protection
impact assessments (DPIAs/AIPAs), define lawful bases (e.g., public interest in
public health), minimize data, and design for portability/subject rights.
5) Equity requires
investment in local language, dataset diversity, and cultural context
Bias remains a salient
risk in computer vision and clinical NLP. Dermatology AI studies continue to
show under-representation and reduced performance on darker skin tones, while
new work highlights hue-related biases beyond light–dark scales—risks directly
relevant to African populations. ScienceDirect+1 At the same time, grassroots capacity
efforts are closing gaps: Masakhane advances African-language NLP resources;
Deep Learning Indaba and DS-I Africa are scaling researcher capacity; Data
Science Africa convenes applied training and collaborations. Data Science Africa+3Masakhane+3Deep Learning Indaba+3
Implication: “Responsibility” must include funded data
diversification (e.g., African skin-of-color datasets), support for local
language NLP, and participatory development with clinicians and communities.
Case Snapshots
A. AI-assisted CXR
for TB screening
B. Digital triage
at national scale in Rwanda
Discussion
SSA experiences
illustrate that “responsible” at scale is multi-dimensional: technical
performance is necessary but insufficient without regulatory fit, data
protection compliance, equity, and sustainability.
Continental and national policy advances reduce ambiguity—the AU strategy
clarifies principles and coordination opportunities; WHO provides detailed
expectations for regulators and implementers. African Union+1
Operationally, TB CAD
shows how AI can close diagnostic gaps when embedded in programmatic pathways
and governed through lifecycle monitoring. Conversely, the Rwanda triage case
highlights that vendor solvency and data portability are not peripheral—they
are core to continuity and trust. The Lancet+2ScienceDirect+2
Equity requires active
correction of data and model blind spots (skin tone, language, culture).
Community-driven capacity networks (Masakhane, Indaba, DS-I Africa) are not
merely “nice to have”; they are structural enablers for localization,
oversight, and sustainability. Masakhane+2Deep Learning Indaba+2
Recommendations: A
Responsible-by-Design Checklist for SSA Health AI
Limitations
This synthesis relies
on publicly available guidance and studies; national implementations vary, and
unpublished program evaluations may alter specific conclusions. TB CAD evidence
is stronger than for some other clinical AI domains (e.g., dermatology in
primary care), where equity risks remain active areas of research. The Lancet+1
Conclusion
Scaling responsible AI
for health in SSA is feasible when anchored in risk-based regulation, rigorous
local validation, enforceable data protection, equity investments, and
sustainability planning. Regional capacity ecosystems and national digital
backbones provide the scaffolding for durable, locally owned AI systems that
measurably improve care while safeguarding rights. The lessons from TB
screening and Rwanda’s digital triage illustrate both the upside and the
operational guardrails needed for responsible scale. World Health Organization+2World Health Organization+2
References
African Union. (2024).
Continental Artificial Intelligence Strategy. Addis Ababa: AU. African Union
HISP Centre / DHIS2.
(n.d.). HISP network overview. University of Oslo. DHIS2
Kenya Office of the
Data Protection Commissioner (ODPC). (2024). Guidance Note on the Processing
of Health Data. Nairobi: ODPC. odpc.go.ke
Nigeria Federal
Government. (2023). Nigeria Data Protection Act (NDPA). Abuja. (See also
KPMG explanatory memorandum). KPMG Assets
Rwanda Ministry of
Health. (2025). New Health Intelligence Center to drive real-time,
evidence-based decisions. Kigali. moh.gov.rw
South Africa
Government. (2020–2021). Protection of Personal Information Act (POPIA)
commencement and compliance. Pretoria. Government of South Africa+1
The Lancet Digital
Health. (2024). Computer-aided detection of tuberculosis from chest
radiographs. The Lancet
WHO. (2021). Ethics
and governance of artificial intelligence for health. Geneva: World Health
Organization. World Health Organization
WHO. (2023). Regulatory
considerations on artificial intelligence for health. Geneva: World Health
Organization. World Health Organization
WHO. (2024/2025). Use
of computer-aided detection software for tuberculosis screening: Implementation
guide. Geneva: WHO Global TB Programme. World Health Organization
Digital Connected Care
Coalition. (2024). Scaling digital healthcare solutions in Rwanda: Lessons
learned from Babyl. DCCC
Badrie, S. (2025). Skin
tone bias in AI dermatology tools. RCSI Student Medical Journal. RCSIsmj
Leave a comment